{"name":"CoA Therapeutics, Inc., a BridgeBio company","slug":"coa-therapeutics-inc-a-bridgebio-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2AJBVV95cUxPYVJxTkNhd1NzREFJVkFWSWp5bFlyc1YwZGpjdjJOZnI4SzNUM0RNdXRtWlZTc21rUGhvbmZ4VWRmT3Fuemhrck95Rjc5c0hBdmRpRFRBR2J4dWxJUEx5cDlvb0JQUWVjTWtmLS1saDhzNXEwMzVWcFg4TFdVeDVoLVVzb0x5VWljbTFQWVBGS2tjMzlzVjAzWUNkY1l5Y3NMODJFdEVXUDgtM1dLZ3k2c3FZMTE3VFFTaTdJQ09zZFNSLXdzVXp0YkI2dmZ1NkNxTkFqUk1DNm5PdmRwUEZ2RXdvN01rWnJrUk9WQmNQeVZBNFJyZnVrWFlyUGZDTzJTSGc2dzBucEh6Z0RtM1FFQ3J0OFc0eVAzQ1o3VGRyQ0NHUGRoZ3Y5OE92aG9sNjFhOGRlNUJ6V2ltS2hyaGtXcWNCZnFBcWhRTnBONGxNaG9uTFdNUU5vYg?oc=5","date":"2024-06-11","type":"pipeline","source":"PR Newswire","summary":"QurAlis Expands Leadership Team With Doug Williamson, M.D., as Chief Medical Officer and Jason Brown, MBA, as Chief Financial Officer and Appoints Shafique Virani, M.D., to Board of Directors - PR New","headline":"QurAlis Expands Leadership Team With Doug Williamson, M.D., as Chief Medical Officer and Jason Brown, MBA, as Chief Fina","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxORWhCaVA2VWRzSkItcDc0S1ExemZOSnFZdG0wdEpxaTlqc1pMM3ZxN1RaZmx6WUdpN1pSZ3dGUzBjaEItbnhEVjcxWFdkcEZWU1NMQmtMMkdWZ29OczZBTVJSS3JGSW1MMkE5VW9vekVHa0JMU0FJZTlNVFV0SjFudjZiV1NGQzlIa2F3VnFnZWI2U081Rlo5Vk1iWUxGbVBqU0YwbUkxcEIwQ1NfcFd3LXB4dE4wbng3SlE?oc=5","date":"2024-03-27","type":"pipeline","source":"Business Wire","summary":"Noetik Appoints Dr. Shafique Virani as Chief Business Officer - Business Wire","headline":"Noetik Appoints Dr. Shafique Virani as Chief Business Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNa3IzVFgwNzI3SjM0b2hhaWF2a0xtWm81NXJQTzB3SUp0UXN4V1BxZ0Uxb2NRMW5pSnJ1dU1VYnZJT2JzMU9JbEVqLWczQmJSQVJFYS16S3E5WlpCalpGWmFpOVg1WEQ1SnJrdmtMM25CaHFraHlWcWo2YnBjUmZzSy10SGhMRTc3RjdxX0tnUmt2eXBMYVVRQUNMZzFVWUxZckEwbHZ4cnp2OU5VMjFDN2tTRUk1c095U3ZjRmhJN0RMQjZLMEJWUXN3?oc=5","date":"2023-09-14","type":"pipeline","source":"Seeking Alpha","summary":"Recursion Pharmaceuticals: Leveraging AI To Discover Novel Therapeutics (NASDAQ:RXRX) - Seeking Alpha","headline":"Recursion Pharmaceuticals: Leveraging AI To Discover Novel Therapeutics (NASDAQ:RXRX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxNQTFEUG1PS3doV05Xb2dKUy1kaHdoN2Z6VTgzNXdiWl8wOEJQWlFmdWdKdWs3REx0TWtybWtJN2VTRlpaVW5pNTR2Y1M1Uk8xRmtKSHRBeWZvLUcyOVBQejJaT2lac280Z2RUaDBWV0xIUXhxMEhDeFB3VEtZb3Z3S1Itbm1WLVotOFVTSWcxSzg3enZiQXhYT1d0NkMyeXJSLV9OYm9aSUtSOXJMZHh0NEthUm52dlBEak95Y2pSb1daTUNmVXl6b0hTRktxdlMtZXlfc0s4RU1seXRIblBxLQ?oc=5","date":"2021-09-15","type":"pipeline","source":"stjude.org","summary":"Research reveals new treatment strategy for propionic acidemia - stjude.org","headline":"Research reveals new treatment strategy for propionic acidemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQc2J5dnpkbXRzanhLMWdLYzh2RTFtelFlWFk1Vmh4QmV1dk9jRllSNWlYV21HWUpWMzFSTkhkY0xBdGNkLS1SMzZubjdXYUtRaHppb2FRZlVSNlE1RG5oWUhzRmZlVEdibFdUS19TTFI3c2l1bGdaMWFlX2FEWU5yeVRXUXlKNXJFLTF4aU9lSlJKZTVUMmM5QmtFZ3MyalAwNUFQUFB2RFg?oc=5","date":"2020-03-20","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Bristol Myers Squibb appoints Mily to strategy lead - Fierce Biotech","headline":"Chutes & Ladders—Bristol Myers Squibb appoints Mily to strategy lead","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOYXBZbU9ERzBsRURabU1zdF9LdkMtaXk3bmwtYlpMRFdCVHpkTExmS2hiTWgtakdGYnlnalUydWUwWHY1YW5HbGFJVVNGMGlITXVqdHpjNzdfREducDFLMjBvbTdZYXkwX1lNNE96N0h3YTF1OVNVdzMyRFNRUmp5MEFCOWhaOW5sVlN6Y3pB?oc=5","date":"2019-01-23","type":"pipeline","source":"Fierce Biotech","summary":"KKR, Viking Global lead $299M round for BridgeBio - Fierce Biotech","headline":"KKR, Viking Global lead $299M round for BridgeBio","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}